Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional implications of glycans and their curation: insights from the workshop held at the 16th Annual International Biocuration Conference in Padua, Italy.

Database : the journal of biological databases and curation·2024
Same author

Cataloging natural sialic acids and other nonulosonic acids (NulOs), and their representation using the Symbol Nomenclature for Glycans.

Glycobiology·2023
Same author

CTO: a Community-Based Clinical Trial Ontology and its Applications in PubChemRDF and SCAIView.

CEUR workshop proceedings·2022
Same author

CAS Common Chemistry in 2021: Expanding Access to Trusted Chemical Information for the Scientific Community.

Journal of chemical information and modeling·2022
Same author

Enhancing the interoperability of glycan data flow between ChEBI, PubChem and GlyGen.

Glycobiology·2021
Same author

InChI version 1.06: now more than 99.99% reliable.

Journal of cheminformatics·2021

Related Experiment Video

Updated: Apr 6, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

8.0K

Reporting biological assay screening results for maximum impact.

Evan Bolton1

  • 1National Center for Biotechnology Information, Bldg. 38A/8S810, National Library of Medicine, U.S. National Institutes of Health, 8600 Rockville Pike, Bethesda, MD 20894, USA.

Drug Discovery Today. Technologies
|July 22, 2015
PubMed
Summary

Public biological screening data is difficult to analyze due to inconsistent reporting. Implementing minimum reporting guidelines for assay protocols and endpoints is crucial for data reproducibility and integration.

More Related Videos

A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans
08:49

A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans

Published on: March 20, 2018

9.6K
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K

Related Experiment Videos

Last Updated: Apr 6, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

8.0K
A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans
08:49

A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans

Published on: March 20, 2018

9.6K
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.3K

Area of Science:

  • Biomedical data science
  • Pharmacology
  • Drug discovery

Background:

  • Vast amounts of biological assay screening data are publicly available.
  • Analysis and comparison of this data are hindered by missing experimental details and non-standardized terminology for assay protocols and endpoints.

Purpose of the Study:

  • To highlight the challenges in utilizing public biological assay screening data.
  • To advocate for the adoption of minimum reporting guidelines to improve data utility.

Main Methods:

  • Literature review on existing biological assay data repositories.
  • Analysis of common data inconsistencies and terminology gaps.
  • Review of current minimum reporting guidelines for biological assays.

Main Results:

  • Significant heterogeneity exists in the reporting of assay protocols and endpoints across public datasets.
  • Lack of standardized terminology impedes data integration and comparative analysis.
  • Existing minimum reporting guidelines, if adopted, can significantly enhance data usability.

Conclusions:

  • Standardized reporting of assay details is essential for maximizing the value of public biological screening data.
  • Adherence to minimum reporting guidelines will improve data reproducibility, integration, comparison, and analysis.
  • Wider adoption of reporting standards is recommended for the scientific community.